Feline Hypokalemia Study Guide

Overview and Clinical Importance

Hypokalemia is defined as a serum potassium concentration less than 3.5 mEq/L (mmol/L). It is one of the most common electrolyte abnormalities encountered in feline practice and represents a significant category on the NAVLE. Potassium is the body's major intracellular cation, with approximately 95-98% located within the intracellular fluid compartment. Potassium is responsible for maintaining the resting cell membrane potential, making it essential for normal neuromuscular function.

Cats are particularly susceptible to hypokalemia due to their unique anatomy (absence of a complete nuchal ligament) and their predisposition to chronic kidney disease. The hallmark clinical sign of feline hypokalemia is cervical ventroflexion - the inability to raise the head into a normal position, creating a characteristic "drooped head" appearance.

Potassium Physiology

Normal Potassium Homeostasis

The normal serum potassium concentration in cats is 3.5 to 5.5 mEq/L. Potassium homeostasis is maintained through a balance between dietary intake and excretion, primarily via the kidneys. The Na+/K+-ATPase pump maintains the steep concentration gradient between intracellular (approximately 140 mEq/L) and extracellular (approximately 4 mEq/L) compartments.

Key functions of potassium:

• Maintains resting cell membrane potential
• Essential for action potential generation in nerve and muscle tissue
• Regulates cardiac rhythm and conduction
• Involved in acid-base balance
• Affects renal concentrating ability

Hypokalemia Severity Classification

Etiology and Pathophysiology

Causes of Feline Hypokalemia

Hypokalemia in cats can be classified into three major mechanisms:

Burmese Hypokalemic Periodic Polymyopathy (BHP)

Burmese Hypokalemic Polymyopathy (BHP) is an autosomal recessive hereditary disease caused by a nonsense mutation in the WNK4 gene (c.2899C>T), which codes for lysine-deficient 4 protein kinase. This enzyme is primarily expressed in the distal nephron and is involved in sodium/potassium exchange mechanisms.

Affected Breeds: Burmese, Tonkinese, Bombay, Burmilla, Asian, Australian Mist, Cornish Rex, Devon Rex, Singapura, Sphynx, and Tiffanie cats.

Key Features:

• Usually presents in kittens 2-6 months of age (occasionally up to 2 years)
• Episodes are typically periodic or episodic, often triggered by stress, exercise, or cold
• Characterized by ventroflexion of neck, muscle weakness, stiff gait, dorsal scapular protrusion
• Serum K+ typically less than 3.0 mmol/L during episodes with elevated CK
• Responds well to potassium supplementation; genetic testing available

Board Tip - Memory Aid for BHP: "BURMESE = B.U.R.M.E.S.E." - Born (young onset), Upright head impossible (ventroflexion), Recessive inheritance, Muscle weakness episodic, Exercise/stress triggered, Serum K+ low, Easy to treat (K+ supplements). Remember WNK4 mutation is the FIRST animal model for hypokalemia linked to this gene!

Feline Primary Hyperaldosteronism (Conn's Syndrome)

Primary hyperaldosteronism is the most common adrenocortical disease in cats and an important cause of refractory hypokalemia. It results from autonomous aldosterone secretion, usually from a unilateral adrenocortical adenoma or adenocarcinoma.

Clinical Triad: Hypokalemia (less than 3.0 mEq/L in 90% of cases), systemic hypertension, and adrenal mass

Key Laboratory Findings:

• Profound hypokalemia (less than 3.0 mEq/L) - often first abnormality detected
• Elevated creatine kinase (CK) in 95% of cases
• Elevated plasma aldosterone concentration (greater than 90% of cases)
• Mild azotemia (50% of cases) - often concurrent CKD
• Suppressed plasma renin activity

Clinical Signs and Presentation

Neuromuscular Manifestations

Clinical signs typically develop when serum potassium falls below 2.5-3.0 mEq/L. The pathophysiology involves hyperpolarization of the muscle cell membrane potential, making cells less excitable and leading to muscle weakness.

Diagnosis

Laboratory Findings

ECG Changes in Hypokalemia

ECG changes typically appear when serum K+ falls below 2.5 mEq/L, although they are less consistent in cats compared to dogs and humans.

Characteristic ECG findings:

• T-wave flattening or inversion
• Prominent U waves (positive deflection after T wave)
• Prolonged QT (or QU) interval
• ST segment depression
• Increased P wave amplitude
• Supraventricular or ventricular arrhythmias

Differential Diagnosis for Cervical Ventroflexion

• Hypokalemia (most common)
• Thiamine (Vitamin B1) deficiency
• Polymyositis/immune-mediated myopathy
• Myasthenia gravis
• Organophosphate toxicity
• Hyperthyroidism
• Other electrolyte abnormalities (hypocalcemia, hypernatremia)

Treatment

Intravenous Potassium Supplementation

Severe hypokalemia (less than 2.5 mEq/L) or symptomatic patients require IV potassium chloride (KCl) supplementation. CRITICAL: Potassium should NEVER be given as a bolus - rapid IV administration can cause fatal cardiac arrhythmias.

IV Potassium Supplementation Guidelines

Critical IV Potassium Rules

• Maximum rate: 0.5 mEq/kg/hr (K-max) - rates up to 1.0-1.5 mEq/kg/hr only for life-threatening hypokalemia with ECG monitoring
• Maximum peripheral concentration: 60 mEq/L - higher concentrations cause thrombophlebitis; use central line for greater than 60 mEq/L
• Mix thoroughly - potassium settles to bottom of bag
• Label bags clearly - prevent accidental bolusing
• Monitor serum K+ every 4-6 hours when supplementing at greater than 0.1-0.2 mEq/kg/hr
• Correct concurrent hypomagnesemia - hypokalemia may be refractory without magnesium repletion

Oral Potassium Supplementation

For mild hypokalemia or chronic maintenance therapy, oral supplementation is preferred. Potassium gluconate is well-tolerated and palatable for cats (potassium chloride is less palatable).

Condition-Specific Treatment

Prognosis

Prognosis depends on the underlying cause and severity of hypokalemia:

• BHP: Excellent with potassium supplementation; some cats may eventually not require ongoing medication
• CKD-associated: Guarded to good; potassium supplementation improves quality of life but does not reverse CKD
• Hyperaldosteronism (surgical): Good to excellent; median survival greater than 1,297 days post-adrenalectomy
• Acute/transient causes: Excellent with appropriate treatment